Bristol-Myers seeks to buy remainder of ImClone
(AFP)
Unusual Little Blurbs
AFP - Bristol-Myers Squibb, the US pharmaceuticals group, said Thursday it has offered to buy its biotechnology partner ImClone Systems in an all-cash deal worth around 4.5 billion dollars.